Sign in

CIK 0000318306 · Non-accelerated filer<br>Smaller reporting company

ABEONA THERAPEUTICS INC.

Sign in to watch
Ticker
ABEO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
830221517
Phone
646-813-4701
Business address
6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, OH, 44103
Former names
PLASMATECH BIOPHARMACEUTICALS INC, ACCESS PHARMACEUTICALS INC, CHEMEX PHARMACEUTICALS INC
  1. 4 Open-market sale Chief Commercial Officer sold 5,548 shares at $5.96 ($33,073)
  2. 4 Grant or award Director acquired 32,751 shares (grant or award)
  3. 3 Insider Initial Statement of Ownership
  4. 4 Planned sale Chief Executive Officer sold 29,985 shares at $4.38 ($131,481)
  5. 4 Open-market sale Chief Financial Officer sold 785 shares at $4.76 ($3,737)
  6. 4 Open-market sale Director sold 20,070 shares at $5.09 ($102,168)
  7. 4 Open-market sale Director sold 14,814 shares at $5.09 ($75,412)
  8. 4 Open-market sale Director sold 16,284 shares at $5.09 ($82,895)
  9. 4 Open-market sale Director sold 18,065 shares at $5.09 ($91,962)
  10. 4 Open-market sale Director sold 2,000 shares at $5.09 ($10,181)
  11. 4 Grant or award Director acquired 37,313 shares (grant or award)
  12. 4 Grant or award Director acquired 37,313 shares (grant or award)
  13. 4 Grant or award Director acquired 37,313 shares (grant or award)
  14. 4 Grant or award Director acquired 37,313 shares (grant or award)
  15. 4 Grant or award Director acquired 37,313 shares (grant or award)
  16. 4 Grant or award Director acquired 37,313 shares (grant or award)
  17. 4 Grant or award Director acquired 37,313 shares (grant or award)
  18. 4 Grant or award Director acquired 37,313 shares (grant or award)
  19. 4 Open-market sale Chief Commercial Officer sold 12,610 shares at $5.29 ($66,658)
  20. 3 Insider Initial Statement of Ownership

Page 2 of 20 · 393 filings